MedPath

Randomized, double blind, placebo controlled clinical study to evaluate oftopical ibuprofen gel for the inhibition of bone loss in chronic periodontitis.

Phase 2
Conditions
Periodontal diseases.
Periodontal diseases
Registration Number
IRCT2014050517587N1
Lead Sponsor
Deputy of Research Council Of Dental Branch, Islamic Azad University of Tehran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
22
Inclusion Criteria

Inclusion Criteria: Systemically healthy patients with chronic periodontitis with periodontal pockets 4 millimeters deep or more at the both sides of posterior teeth in Mandibular Jaw.

Exclusion Criteria

Existing systemic disease; Pregnancy; Lactation; Smokers; Patients who had taken any kind of medication during the previous six months; No periodontal treatment the previous six months; Hypersensitive to Ibuprofen; Orthodontic treatment; Cancer and Chemotherapy; Numerous large caries; The use of any mouthwash during the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pocket depth. Timepoint: 15 Days. Method of measurement: Periodontal Probe.;Bleeding on probing. Timepoint: 15. Method of measurement: Periodontal Probe.
Secondary Outcome Measures
NameTimeMethod
Increased alveolar bone density. Timepoint: 3 months. Method of measurement: Bone densitometer machine.;Reduction of plaque index. Timepoint: 3 Months. Method of measurement: Loe & Silness Index.
© Copyright 2025. All Rights Reserved by MedPath